EN
HI
Summary
As of 29 Oct, 2026, Senores Pharmaceuticals stock price is ₹1219.2. During the trading session, the stock has moved between an intraday low of ₹1208.00 and an intraday high of ₹1339.50. Over the last 52 weeks, Senores Pharmaceuticals has traded between ₹706.00 and ₹1599.00.
The stock has recorded a trading volume of 10,74,001 shares,. Its Average Traded Price (ATP) is ₹1260.16, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹1219.20.
Senores Pharmaceuticals has an upper circuit limit of ₹1589.10 and a lower circuit limit of ₹1059.50. The total value traded stands at ₹135.34 CR, and the delivery percentage for the day is 49.15%.
The stock is currently traded with a market lot size of 1. Senores Pharmaceuticals also offers a dividend yield of 0%.
Senores Pharmaceuticals Share Price Chart
Senores Pharmaceuticals Share Key Metrics
Volume
10.74 L
Market Cap
5614.85 CR
LTQ@LTP
1@1219.20
ATP
1260.16
Var Margin
20.32 %
Circuit Range
1059.5-1589.1
Delivery %
49.15 %
Value
135.34 CR
ASM/GSM
No
Market Lot
1
Senores Pharmaceuticals Fundamentals
P/E Ratio
48.25
P/B Ratio
6.33
Div. Yield
0
Sector P/E
39.87
Sector P/B
3.27
Sec. Div. Yield
0.53
Senores Pharmaceuticals Resistance and Support
Pivot 1325
Resistance
First Resistance
1340.3
Second Resistance
1356.3
Third Resistance
1371.6
Support
First Support
1309
Second Support
1293.7
Third Support
1277.7
Senores Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Oct 29 2026 | 1324.3 | 1219.2 | -7.94% | 1339.5 | 1208 |
| Wed Oct 28 2026 | 1315 | 1324.3 | 1.01% | 1341 | 1309.69 |
| Tue Oct 27 2026 | 1255 | 1311 | 5.26% | 1318 | 1248.9 |
Senores Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-29 | Quarterly Results |
| 2026-07-27 | Quarterly Results |
| 2026-05-14 | Audited Results |
| 2026-01-20 | Quarterly Results & Others |
| 2026-01-07 | Others |
| 2025-11-06 | Quarterly Results |
| 2025-07-23 | Quarterly Results & Others |
| 2025-05-15 | Audited Results |
| 2025-01-23 | Quarterly Results & Others |
Senores Pharmaceuticals News
Senores Pharmaceuticals Ltd - 544319 - Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Senores Pharmaceuticals announced a Rs.43 crore capacity expansion across three of its subsidiary companies in the US and India. The project aims to add 1.5 billion units and a new Prefilled Syringe line, expected to be completed by March 2027 via internal accruals and IPO proceeds.
Oct 29 2026 14:01:22
Senores Pharmaceuticals Ltd - 544319 - Board Meeting Outcome for Outcome Of Board Meeting Held On October 29,2026
Senores Pharmaceuticals reported Q2 FY27 cons. revenue of ₹192 crores (up 25% YoY) and net profit of ₹37 crores (up 22% YoY). The board also approved the appointment of M/s Talati and Talati LLP as joint statutory auditors for the period 2026-27 to 2030-31.
Oct 29 2026 13:51:53
Read More
Senores Pharmaceuticals Management
| Name | Position |
|---|---|
| Vinay Kumar Mishra | Company Secretary & Compliance Officer |
| Swapnil Jatinbhai Shah | Managing Director |
Senores Pharmaceuticals Similar Stocks
Sanofi India Ltd.
3189.50
197.50 (6.60%)
Bliss GVS Pharma Ltd.
680.90
32.40 (5.00%)
Kovai Medical Center & Hospital Ltd.
5896.00
-33.50 (0.56%)
Nephrocare Health Services Ltd.
628.55
0.15 (0.02%)
Innova Captab Ltd.
1051.10
1.40 (0.13%)
FDC Ltd.
377.15
0.60 (0.16%)
IOL Chemicals And Pharmaceuticals Ltd.
184.93
4.31 (2.39%)
Supriya Lifescience Ltd.
869.30
7.05 (0.82%)
Sahajanand Medical Technologies Ltd.
476.55
5.50 (1.17%)
Senores Pharmaceuticals FAQs
The Buying Price of Senores Pharmaceuticals share is 1219.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Senores Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Senores Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Senores Pharmaceuticals shares is 48.25. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Senores Pharmaceuticals shares is 6.33. Useful to assess the stock's value relative to its book value.
To assess Senores Pharmaceuticals’s valuation compare Sector P/E, P/B which are 39.87 & 3.27 with sector averages, along with growth rates and financial metrics.
The Market Cap of Senores Pharmaceuticals is 5614.85 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Senores Pharmaceuticals share price is 1599.00 & 706.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Senores Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in SENORES
